213 related articles for article (PubMed ID: 9733855)
1. Persistent infection of Epstein-Barr virus-positive B lymphocytes by human herpesvirus 8.
Kliche S; Kremmer E; Hammerschmidt W; Koszinowski U; Haas J
J Virol; 1998 Oct; 72(10):8143-9. PubMed ID: 9733855
[TBL] [Abstract][Full Text] [Related]
2. [Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV, HHV-8)].
Katano H
Uirusu; 2010 Dec; 60(2):237-45. PubMed ID: 21488336
[TBL] [Abstract][Full Text] [Related]
3. Human herpesvirus 8 induces polyfunctional B lymphocytes that drive Kaposi's sarcoma.
Knowlton ER; Rappocciolo G; Piazza P; Lepone LM; Nadgir SV; Bullotta A; Berendam SJ; Li J; Reinhart TA; Jenkins FJ; Rinaldo CR
mBio; 2014 Sep; 5(5):e01277-14. PubMed ID: 25182322
[TBL] [Abstract][Full Text] [Related]
4. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
Callahan J; Pai S; Cotter M; Robertson ES
Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus recombinants from BC-1 and BC-2 can immortalize human primary B lymphocytes with different levels of efficiency and in the absence of coinfection by Kaposi's sarcoma-associated herpesvirus.
Aguirre AJ; Robertson ES
J Virol; 2000 Jan; 74(2):735-43. PubMed ID: 10623735
[TBL] [Abstract][Full Text] [Related]
6. Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma.
Monini P; Colombini S; Stürzl M; Goletti D; Cafaro A; Sgadari C; Buttò S; Franco M; Leone P; Fais S; Leone P; Melucci-Vigo G; Chiozzini C; Carlini F; Ascherl G; Cornali E; Zietz C; Ramazzotti E; Ensoli F; Andreoni M; Pezzotti P; Rezza G; Yarchoan R; Gallo RC; Ensoli B
Blood; 1999 Jun; 93(12):4044-58. PubMed ID: 10361101
[TBL] [Abstract][Full Text] [Related]
7. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 infection in reactive lymphoid tissues: a model for KSHV/HHV-8-related lymphomas?
Lazzi S; Bellan C; Amato T; Palummo N; Cardone C; D'Amuri A; De Luca F; Beyanga M; Facchetti F; Tosi P; Leoncini L
Hum Pathol; 2006 Jan; 37(1):23-31. PubMed ID: 16360412
[TBL] [Abstract][Full Text] [Related]
8. Restricted expression of Epstein-Barr virus (EBV)-encoded, growth transformation-associated antigens in an EBV- and human herpesvirus type 8-carrying body cavity lymphoma line.
Szekely L; Chen F; Teramoto N; Ehlin-Henriksson B; Pokrovskaja K; Szeles A; Manneborg-Sandlund A; Löwbeer M; Lennette ET; Klein G
J Gen Virol; 1998 Jun; 79 ( Pt 6)():1445-52. PubMed ID: 9634087
[TBL] [Abstract][Full Text] [Related]
9. Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells.
Miller G; Heston L; Grogan E; Gradoville L; Rigsby M; Sun R; Shedd D; Kushnaryov VM; Grossberg S; Chang Y
J Virol; 1997 Jan; 71(1):314-24. PubMed ID: 8985352
[TBL] [Abstract][Full Text] [Related]
10. The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle.
Lear AL; Rowe M; Kurilla MG; Lee S; Henderson S; Kieff E; Rickinson AB
J Virol; 1992 Dec; 66(12):7461-8. PubMed ID: 1331531
[TBL] [Abstract][Full Text] [Related]
11. Maintenance of Epstein-Barr Virus Latent Status by a Novel Mechanism, Latent Membrane Protein 1-Induced Interleukin-32, via the Protein Kinase Cδ Pathway.
Lai KY; Chou YC; Lin JH; Liu Y; Lin KM; Doong SL; Chen MR; Yeh TH; Lin SJ; Tsai CH
J Virol; 2015 Jun; 89(11):5968-80. PubMed ID: 25810549
[TBL] [Abstract][Full Text] [Related]
12. The restricted cellular host range of human herpesvirus 8.
Blackbourn DJ; Lennette E; Klencke B; Moses A; Chandran B; Weinstein M; Glogau RG; Witte MH; Way DL; Kutzkey T; Herndier B; Levy JA
AIDS; 2000 Jun; 14(9):1123-33. PubMed ID: 10894276
[TBL] [Abstract][Full Text] [Related]
13. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
14. Production of inflammatory cytokines by Epstein-Barr virus (EBV)-infected lymphoblastoid cell lines spontaneously originated from the peripheral blood of patients with human immunodeficiency virus (HIV) infection.
Roncella S; Baldi L; Cutrona G; Viale M; Rizzo F; Gasco M; Ferrarini M; Pistoia V
Clin Immunol Immunopathol; 1995 Nov; 77(2):162-71. PubMed ID: 7586723
[TBL] [Abstract][Full Text] [Related]
15. De novo infection and serial transmission of Kaposi's sarcoma-associated herpesvirus in cultured endothelial cells.
Lagunoff M; Bechtel J; Venetsanakos E; Roy AM; Abbey N; Herndier B; McMahon M; Ganem D
J Virol; 2002 Mar; 76(5):2440-8. PubMed ID: 11836422
[TBL] [Abstract][Full Text] [Related]
16. Variable methylation of the Epstein-Barr virus Wp EBNA gene promoter in B-lymphoblastoid cell lines.
Elliott J; Goodhew EB; Krug LT; Shakhnovsky N; Yoo L; Speck SH
J Virol; 2004 Dec; 78(24):14062-5. PubMed ID: 15564516
[TBL] [Abstract][Full Text] [Related]
17. Dynamic Epstein-Barr virus gene expression on the path to B-cell transformation.
Price AM; Luftig MA
Adv Virus Res; 2014; 88():279-313. PubMed ID: 24373315
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus (EBV) infection in B-cell non-Hodgkin's lymphomas in children: virus latency and its correlation with CD21 and CD23 molecules.
Kasprzak A; Spachacz R; Wachowiak J; Stefanska K; Zabel M
Folia Histochem Cytobiol; 2007; 45(3):169-79. PubMed ID: 17951165
[TBL] [Abstract][Full Text] [Related]
19. Rta of murine gammaherpesvirus 68 reactivates the complete lytic cycle from latency.
Wu TT; Usherwood EJ; Stewart JP; Nash AA; Sun R
J Virol; 2000 Apr; 74(8):3659-67. PubMed ID: 10729142
[TBL] [Abstract][Full Text] [Related]
20. Immortalized Epstein-Barr virus-positive B-cell lines obtained by prolonged culture of peripheral blood mononuclear cells from human immunodeficiency virus type 1-positive patients.
Ruibal-Ares B; Belmonte L; Baré P; Scolnik M; Palacios MF; Bayo-Hanza C; Galmarini CM; Mendez G; de Bracco MM
J Hum Virol; 2001; 4(4):200-13. PubMed ID: 11694848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
